A physician investigating unexplained hypercobalaminemia will typically order some combination of the following: Complete blood count (CBC) with differential to check for abnormal red blood cell, white blood cell, or platelet counts Liver function tests (ALT, AST, ALP, bilirubin, albumin) to assess liver health Kidney function tests (creatinine, BUN, estimated GFR) to evaluate renal clearance Peripheral blood smear if a myeloproliferative disorder is suspected Abdominal imaging (ultrasound or CT) if liver or abdominal pathology is a concern Cancer-specific markers or screenings if clinical suspicion warrants them The NIH Office of Dietary Supplements fact sheet notes that observational data from a Danish registry analysis of 757,185 people found the adjusted 1-year cancer risk was 1.74 to 4.72 times higher among those with B12 above 813 pg/mL compared to those in the normal range of 203 to 813 pg/mL
Angle the needle against the vial wall and release the diluent slowly, letting it run down the glass rather than directly onto the lyophilized cake
How is BPC-157 supplied, stored and handled for research
I suspect i will eventually, but currently this works, and Im sticking to it
A rodent-based thyroid boxed warning carries no human signal at trial resolution, with a personal or family history of medullary thyroid cancer or MEN2 as a contraindication
Yes, but people with absorption issues (due to age, diet, or health conditions) may not get sufficient B12 from pills alone
